Tianjin, China

Xinbo Lu

This inventor holds 1 USPTO granted patent. Top assignee: Tianjin Kinsly Pharmaceutical Co. Ltd.. Active years: 2008.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Xinbo Lu

Introduction

Xinbo Lu is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on adefovir dipivoxil. His research and inventions have the potential to impact the treatment of various medical conditions.

Latest Patents

Xinbo Lu holds a patent for a new crystal form of adefovir dipivoxil, which is identified as 9-[2-[bis(pivaloyloxy)-methoxy]-phosphinyl]-methoxyl]-ethyl]-adenine. This patent discloses a method for preparing the crystal, which involves placing adefovir dipivoxil in a round bottom flask, adding an organic solvent, and dissolving the compound ultrasonically to form a solution. The process concludes with spray drying the adefovir dipivoxil solution. This innovative approach enhances the properties of adefovir dipivoxil, making it a valuable asset in pharmaceutical applications.

Career Highlights

Xinbo Lu is currently associated with Tianjin Kinsly Pharmaceutical Co. Ltd., where he continues to advance his research and development efforts. His work has garnered attention in the pharmaceutical industry, showcasing his expertise and commitment to innovation.

Collaborations

Xinbo Lu collaborates with talented individuals such as Guocheng Wang and Qinxuan Liu. These partnerships enhance the research environment and contribute to the successful development of new pharmaceutical solutions.

Conclusion

Xinbo Lu's contributions to the field of pharmaceuticals through his innovative patent on adefovir dipivoxil exemplify the importance of research and development in medical science. His work not only reflects his dedication as an inventor but also holds promise for future advancements in treatment options.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…